Literature DB >> 7976225

HIV-1 associated neuropathies in males; impotence and penile electrodiagnosis.

S T Ali1, R N Shaikh, A Siddiqi.   

Abstract

Value of the bulbocavernosus reflex latency versus nerve conduction velocity of the dorsal nerve of penis and penile brachial index was evaluated in HIV-1 infected asymptomatic and symptomatic men with and without an objective evidence of neuropathy. These studies revealed striking results in neuropathic group. Both asymptomatic and symptomatic patients with neuropathy exhibited a significant decrease (P < 0.0005) in the values of the nerve conduction velocity of the dorsal nerve of penis as well as penile brachial index in comparison with the controls of the same age group. However both types of non neuropathic patients showed a non significant difference in the above mentioned parameters with their respective controls. The latency of bulbocavernosus reflex showed no significant difference between the groups and was within the normal limits. A non significant association in the values of the study parameters among asymptomatic and symptomatic patients with and without neuropathy was also observed. These findings suggest an exclusively apparent sexual pathway for the penile dorsal nerve conduction and penile brachial index in both HIV-1 infected asymptomatic and AIDS positive men affected by neuropathic conditions, irrespective of their disease state. We thus conclude that a primary defective neuropathic mechanism may play an etiological role in the pathogenesis of erectile impotence in these patients.

Entities:  

Mesh:

Year:  1994        PMID: 7976225

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  2 in total

1.  Autonomic neuropathy in patients with HIV: course, impact of disease stage, and medication.

Authors:  T Glück; E Degenhardt; J Schölmerich; B Lang; J Grossmann; R H Straub
Journal:  Clin Auton Res       Date:  2000-02       Impact factor: 4.435

2.  Effect of repeated doses of darunavir plus low-dose ritonavir on the pharmacokinetics of sildenafil in healthy male subjects: phase I randomized, open-label, two-way crossover study.

Authors:  V Sekar; E Lefebvre; T De Marez; M De Pauw; E De Paepe; T Vangeneugden; R M W Hoetelmans
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.